NPI registry status
Active
2026 NPPES data Dermatology Physician NPI 1932104502 MD
Verify on CMS → Garry Gewirtzman, MD
Dermatology Physician in Plantation, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 15,011 in Dermatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
243
Medicare Part D claims · 110 beneficiaries · Dermatology Physician avg: 799
MIPS score
75/100
CMS neutral threshold · no category scores published
What the federal data shows
Garry Gewirtzman, MD carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 243 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 243
- Part D claims, 2024
- Likely
- board-certified (heuristic)
- ≥48th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Garry Gewirtzman, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1932104502), first enumerated 06/20/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 243 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- State context
State board disciplinary context
Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Garry Gewirtzman, MD's individual license status. Verify directly with the state medical board.
Source: FLDOH annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1932104502 · Dermatology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-NEUTRAL · RX-LIGHT · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1932104502
- ENUM-LEGACY 2005
- TAX-MID 15K Dermatology Physician
- MIPS-NEUTRAL 75/100
- RX-LIGHT 243
- BOOK-LIGHT 1,166 in Florida
- PHOTO-ENUM David Taylor · 2005
Garry Gewirtzman, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
243 ≥ 48th percentile 48% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Garry Gewirtzman, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Garry Gewirtzman, MD?
CMS neutral score, not measuredPrimary specialty
Dermatology Physician
Medicare Part D claims
243 70% vs specialty avg
MIPS final score
75/100
Specialty distribution in Florida
How Dermatology Physician compares to other specialties among Florida providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1932104502 |
|---|---|
| Specialty | Dermatology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 06/20/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Individual
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Garry Gewirtzman, MD. To verify Garry Gewirtzman, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
243
Total Claims
$4K
Total Drug Cost
110
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 262
- Total Day Supply
- 6,451
- Generic Drug Cost
- $4K
- Antibiotic Claims
- 15
Patient Demographics
- Average Patient Age
- 74.9 years
- Avg HCC Risk Score
- 1.33
- Gender Split
- 43% female / 57% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Garry Gewirtzman, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Triamcinolone Acet…
Triamcinolone Acetonide
48 claims
- Ketoconazole
Ketoconazole
37 claims
- Hydrocortisone
Hydrocortisone
29 claims
- Betamethasone Dipr… 14
Betamethasone Dipropionate
14 claims
- Mupirocin 13
Mupirocin
13 claims
- Clotrimazole-Betam… 12
Clotrimazole-Betamethasone
12 claims
| Drug | Claims |
|---|---|
| Triamcinolone Acetonide | 48 |
| Ketoconazole | 37 |
| Hydrocortisone | 29 |
| Betamethasone Dipropionate | 14 |
| Mupirocin | 13 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatology Physician Overview
How Garry Gewirtzman, MD fits within the Dermatology Physician landscape nationally.
15,011
Dermatology Physician Providers in US
53
States with Dermatology Physician
799
Avg Claims per Provider
Garry Gewirtzman, MD's 243 claims are below the specialty average of 799.
Nationwide Dermatology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Gewirtzman, both outside Florida so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Dermatology Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Gewirtzman.
One of 1,166 Dermatology Physician providers enrolled in Florida, 5 are shown here.
Dr. McKenna Abercrombie Dewees
DO
Brandon, FL
Dr. Bradley Abrams
DO
Sarasota, FL
Dr. Michael Abrouk
MD
Brandon, FL
Dr. David Adams
MD
Miramar Beach, FL
Dr. Kendall Adkisson
M.D.
Jacksonville, FL
Compare Dermatology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Garry Gewirtzman, MD's specialty? ▼
Garry Gewirtzman, MD specializes in Dermatology Physician and practices in Plantation, Florida. Credentials: MD.
How much does Garry Gewirtzman, MD prescribe under Medicare Part D? ▼
In 2024, Garry Gewirtzman, MD wrote 243 Medicare Part D claims totaling $4K in drug costs for 110 beneficiaries.
What is Garry Gewirtzman, MD's Medicare quality score? ▼
Garry Gewirtzman, MD has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Garry Gewirtzman, MD located? ▼
Garry Gewirtzman, MD is located at 261 N. UNIVERSITY DRIVE, Plantation, FL, 33324. Phone: (954) 473-6750.
What is Garry Gewirtzman, MD's NPI number? ▼
Garry Gewirtzman, MD's National Provider Identifier (NPI) is 1932104502, issued on 06/20/2005.
How many Dermatology Physician providers are there in the US? ▼
There are 15,011 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 799 Medicare Part D claims per year.
What drugs does Garry Gewirtzman, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Garry Gewirtzman, MD's most frequently prescribed drugs include Triamcinolone Acetonide, Ketoconazole, Hydrocortisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Garry Gewirtzman, MD accept Medicare? ▼
Garry Gewirtzman, MD appears in CMS Medicare data with 243 Part D claims and 110 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Garry Gewirtzman, MD's credentials? ▼
Garry Gewirtzman, MD's NPI is 1932104502 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.